Dr. Hans Han-Woo Lee, MD

Dr. Lee practices at Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia.

Dr. Lee's NPI, 1881690857, was assigned on June 24, 2005. Dr. Lee graduated from State University of New York at Buffalo School of Medicine in 1992. Dr. Lee holds Georgia license 058269.

Dr. Lee's primary practice is Wellstar Pulmonary Medicine - HOPD, at 55 Whitcher Street, Marietta, GA 30060.

Dr. Lee's primary practice is Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia. Dr. Lee is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Lee to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Lee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Lee is licensed in Georgia.

CMS data shows 9,145 Medicare services from Dr. Lee across 25 procedure codes in 2024, for 1,648 Medicare patients. Medicare paid $194,870 for them.

CMS counts 1,648 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 648 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 74, with 51% women.

In 2024, Dr. Lee wrote 9,292 Medicare Part D claims for 1,018 patients. 84% of them were for generic drugs. CMS names the drug for 9,024 of them, across 68 drugs with 11 or more claims each, at $1,722,962 in total drug cost. In 2023, CMS named 8,028 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links Dr. Lee to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Open Payments lists research payments to Dr. Lee that name 1 trial.

CMS Open Payments shows 541 general payments to Dr. Lee from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,054. It also lists 1 research payment totaling $135 in 2019, naming 1 clinical trial.

Dr. Lee graduated from State University of New York at Buffalo School of Medicine in 1992.